共 843 条
- [1] Vitale MG(2016)Recent developments in second and third line therapy of metastatic renal cell carcinoma Expert Rev Anticancer Ther 16 469-471
- [2] Carteni G(2017)New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy J Hematol Oncol 10 38-2642
- [3] Zarrabi K(2017)Immune checkpoint inhibitors in renal cell carcinoma Clin Sci (Lond) 131 2627-212
- [4] Fang C(1994)Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy J Clin Oncol 12 206-18
- [5] Wu S(2017)The evolving treatment landscape of advanced renal cell carcinoma in patients progressing after VEGF inhibition J Kidney Cancer VHL 4 10-329
- [6] Ross K(2017)New treatment options for metastatic renal cell carcinoma ESMO Open 2 319-S98
- [7] Jones RJ(2017)Evolving treatment paradigm in metastatic renal cell carcinoma Am Soc Clin Oncol Educ Book 37 S93-e177
- [8] Rabinovitch RA(2000)Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe Cancer J Sci Am 6 e170-3590
- [9] Zelefsky MJ(2014)Radiotherapy for renal-cell carcinoma Lancet Oncol 15 3584-924
- [10] Gaynor JJ(2009)Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma J Clin Oncol 27 djv414-2524